
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 627 |
| Issued Applications | 267 |
| Pending Applications | 54 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4898880
[patent_doc_number] => 20080118494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Compositions For Detection Of Latent Hiv Reactivation And Methods Of Using The Same'
[patent_app_type] => utility
[patent_app_number] => 11/661881
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21096
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118494.pdf
[firstpage_image] =>[orig_patent_app_number] => 11661881
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/661881 | Compositions For Detection Of Latent Hiv Reactivation And Methods Of Using The Same | Sep 1, 2005 | Abandoned |
Array
(
[id] => 5743133
[patent_doc_number] => 20060088858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Modified venom and venom components as anti-retroviral agents'
[patent_app_type] => utility
[patent_app_number] => 11/217713
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7301
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088858.pdf
[firstpage_image] =>[orig_patent_app_number] => 11217713
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/217713 | Modified venom and venom components as anti-retroviral agents | Sep 1, 2005 | Abandoned |
Array
(
[id] => 4859150
[patent_doc_number] => 20080268000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Vaccine Stabilising Formula with Live Antigens for Use in Mass Vaccination Systems'
[patent_app_type] => utility
[patent_app_number] => 12/065216
[patent_app_country] => US
[patent_app_date] => 2005-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5971
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20080268000.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065216
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065216 | Vaccine Stabilising Formula with Live Antigens for Use in Mass Vaccination Systems | Aug 31, 2005 | Abandoned |
Array
(
[id] => 5726860
[patent_doc_number] => 20060057620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Treatment of HIV infection'
[patent_app_type] => utility
[patent_app_number] => 11/212906
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3845
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11212906
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/212906 | Treatment of HIV infection | Aug 28, 2005 | Abandoned |
Array
(
[id] => 5533042
[patent_doc_number] => 20090232830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Modified HIV-1 Envelope Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/661210
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17248
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232830.pdf
[firstpage_image] =>[orig_patent_app_number] => 11661210
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/661210 | Modified HIV-1 envelope proteins | Aug 28, 2005 | Issued |
Array
(
[id] => 5125512
[patent_doc_number] => 20070237783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV'
[patent_app_type] => utility
[patent_app_number] => 11/211576
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7168
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237783.pdf
[firstpage_image] =>[orig_patent_app_number] => 11211576
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/211576 | Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV | Aug 25, 2005 | Issued |
Array
(
[id] => 5902489
[patent_doc_number] => 20060045886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'HIV immunostimulatory compositions'
[patent_app_type] => utility
[patent_app_number] => 11/213405
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8161
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20060045886.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213405
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213405 | HIV immunostimulatory compositions | Aug 25, 2005 | Abandoned |
Array
(
[id] => 5902488
[patent_doc_number] => 20060045885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Method of eliciting an immune response against HIV'
[patent_app_type] => utility
[patent_app_number] => 11/213354
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8222
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20060045885.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213354 | Method of eliciting an immune response against HIV | Aug 25, 2005 | Abandoned |
Array
(
[id] => 5563627
[patent_doc_number] => 20090136479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Ubiquitin-like protein isg15 for hiv inhibition'
[patent_app_type] => utility
[patent_app_number] => 11/630544
[patent_app_country] => US
[patent_app_date] => 2005-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10854
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136479.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630544
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630544 | Ubiquitin-like protein isg15 for hiv inhibition | Jun 27, 2005 | Abandoned |
Array
(
[id] => 4959709
[patent_doc_number] => 20080274134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex'
[patent_app_type] => utility
[patent_app_number] => 11/629843
[patent_app_country] => US
[patent_app_date] => 2005-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 44848
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274134.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629843
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629843 | Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex | Jun 14, 2005 | Abandoned |
Array
(
[id] => 5887720
[patent_doc_number] => 20060275321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Polypeptide antagonists of HIV-1 Tat protein'
[patent_app_type] => utility
[patent_app_number] => 11/143550
[patent_app_country] => US
[patent_app_date] => 2005-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7711
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275321.pdf
[firstpage_image] =>[orig_patent_app_number] => 11143550
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/143550 | Polypeptide antagonists of HIV-1 Tat protein | May 31, 2005 | Abandoned |
Array
(
[id] => 5800122
[patent_doc_number] => 20060035249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS'
[patent_app_type] => utility
[patent_app_number] => 11/140311
[patent_app_country] => US
[patent_app_date] => 2005-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 44601
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035249.pdf
[firstpage_image] =>[orig_patent_app_number] => 11140311
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/140311 | Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | May 26, 2005 | Abandoned |
Array
(
[id] => 5440918
[patent_doc_number] => 20090092557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'GRIFFITHSIN, GLYCOSYLATION-RESISTANT GRIFFITHSIN, AND RELATED CONJUGATES, COMPOSITIONS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCTION AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 11/569813
[patent_app_country] => US
[patent_app_date] => 2005-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26336
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20090092557.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569813
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569813 | Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use | May 26, 2005 | Issued |
Array
(
[id] => 6100862
[patent_doc_number] => 20110004951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR IDENTIFYING COMPOUNDS THAT INHIBIT HIV-1 SUBUNIT-SPECIFIC REVERSE TRANSCRIPTASE'
[patent_app_type] => utility
[patent_app_number] => 10/599851
[patent_app_country] => US
[patent_app_date] => 2005-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 27366
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20110004951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599851
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599851 | METHODS AND COMPOSITIONS FOR IDENTIFYING COMPOUNDS THAT INHIBIT HIV-1 SUBUNIT-SPECIFIC REVERSE TRANSCRIPTASE | May 23, 2005 | Abandoned |
Array
(
[id] => 4873816
[patent_doc_number] => 20080200550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein'
[patent_app_type] => utility
[patent_app_number] => 11/597431
[patent_app_country] => US
[patent_app_date] => 2005-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 39944
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200550.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597431
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597431 | Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein | May 23, 2005 | Abandoned |
Array
(
[id] => 7110594
[patent_doc_number] => 20050208049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy'
[patent_app_type] => utility
[patent_app_number] => 11/131687
[patent_app_country] => US
[patent_app_date] => 2005-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6475
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208049.pdf
[firstpage_image] =>[orig_patent_app_number] => 11131687
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/131687 | Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy | May 16, 2005 | Abandoned |
Array
(
[id] => 5894412
[patent_doc_number] => 20060002951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Inhibition of the tRNALys3-primed initiation of reverse transcription in HIV-1 by APOBEC3G'
[patent_app_type] => utility
[patent_app_number] => 11/129442
[patent_app_country] => US
[patent_app_date] => 2005-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 25202
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002951.pdf
[firstpage_image] =>[orig_patent_app_number] => 11129442
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/129442 | Inhibition of the tRNALys3-primed initiation of reverse transcription in HIV-1 by APOBEC3G | May 15, 2005 | Abandoned |
Array
(
[id] => 7110617
[patent_doc_number] => 20050208072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Preventive and therapeutic aids vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/126498
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11962
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208072.pdf
[firstpage_image] =>[orig_patent_app_number] => 11126498
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/126498 | Preventive and therapeutic aids vaccines | May 9, 2005 | Abandoned |
Array
(
[id] => 211219
[patent_doc_number] => 07622125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-24
[patent_title] => 'Polycistronic HIV vector constructs'
[patent_app_type] => utility
[patent_app_number] => 11/124602
[patent_app_country] => US
[patent_app_date] => 2005-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 27519
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/622/07622125.pdf
[firstpage_image] =>[orig_patent_app_number] => 11124602
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/124602 | Polycistronic HIV vector constructs | May 4, 2005 | Issued |
Array
(
[id] => 5808507
[patent_doc_number] => 20060094862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Specificity exchangers that redirect antibodies to a pathogen'
[patent_app_type] => utility
[patent_app_number] => 11/121282
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21090
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094862.pdf
[firstpage_image] =>[orig_patent_app_number] => 11121282
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/121282 | Specificity exchangers that redirect antibodies to a pathogen | May 2, 2005 | Abandoned |